AdaptHealth Corp. Announces Second Quarter 2026 Results
AdaptHealth reported Q2 revenue of $740.3 million, up 12.7% year-over-year, but swung to a net loss of $145.3 million driven by a $144.2 million goodwill impairment. The company significantly lowered its full-year Adjusted EBITDA guidance to $490 million-$520 million, down from the prior $680 million-$730 million range, citing margin pressure from capitated contracts and a manufacturer price increase.
Key figures
- Revenue
- $740.3 million
- Guidance
- FY26 revenue $2.85B-$2.89B; Adjusted EBITDA $490M-$520M (lowered from $680M-$730M); FCF $80M-$120M
- Revenue Yoy
- 12.7%
- Myapp users
- 512000
- Deal value usd
- 235000000
- Adjusted ebitda
- $132.0 million
- Goodwill impairment
- $144.2 million
- Restructuring savings
- $19 million
- Organic revenue growth
- 15.9%
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.